Frances Shepherd is a global leader in the development of effective therapy for the most dangerous forms of lung cancer. At a time when the outlook for patients with lung cancer was extremely grim, she launched a bold research program through the National Cancer Institute of Canada, the Princess Mar
Date: Sep 23, 2016
Source: Google
Merck KGaA Lung-Cancer Drug Misses Trial's Survival Goal
It is disappointing that the testing did not meet itsprimary endpoint, Frances Shepherd, a medical professor at theUniversity of Toronto who coordinated the trial, said in thestatement. However, notable treatment effects were observed incertain subgroups of patients and warrant further inve